흰쥐의 포르말린시험에서 복강 내로 투여한 비선택적 산화질소합성효소 억제제의 항통각효과

The Antinociceptive Effect of Intraperitoneally Administered Nonselective Nitric Oxide Synthase Inhibitor on the Rat Formalin Test

  • 오민혜 (충남대학교 의과대학 마취통증의학교실) ;
  • 이원형 (충남대학교 의과대학 마취통증의학교실) ;
  • 고영권 (충남대학교 의과대학 마취통증의학교실)
  • Oh, Minhye (Department of Anesthesiology and Pain Medicine, College of Medicine, Chungnam National University) ;
  • Lee, Wonhyung (Department of Anesthesiology and Pain Medicine, College of Medicine, Chungnam National University) ;
  • Go, Youngkwon (Department of Anesthesiology and Pain Medicine, College of Medicine, Chungnam National University)
  • 투고 : 2006.08.04
  • 심사 : 2006.10.09
  • 발행 : 2006.12.30

초록

Background: Nitric oxide (NO) is involved in the transmission and modulation of nociceptive information at the peripheral, spinal cord and supraspinal levels. We conducted this experiment to assess the antinociceptive effects of a nonselective nitric oxide synthase (NOS) inhibitor, N-nitro-L-arginine methyl ester (L-NAME), on the modulation of pain in rats subjected to the formalin test. Methods: Formalin 5% was injected in the right hind paw after intraperitoneal (IP) injection of various doses of L-NAME (0.5 mg/kg, 1.5 mg/kg with and without L-arginine 100 mg/kg, 5.0 mg/kg). The number of flinches was measured. Results: Formalin injected into the rat hind paw induced a biphasic nociceptive behavior. IP injected L-NAME diminished the nociceptive behaviors in a dose-dependent manner during phases 1 and 2. The concomitant injection of L-arginine reversed the antinocipetive effect of L-NAME. Conclusions: The data demonstrates that a nonselective NOS inhibitor, L-NAME, possesses antinociceptive properties in rats subjected to the formalin test, and the antinociceptive effect of L-NAME is reversed by the concomitant administration of L-arginine.

키워드

참고문헌

  1. Garthwaite J, Charles SL, Chess-Williams R: Endothelium-derived relaxing factor release on activation of NMDA receptors suggests role as intercellular messenger in brain. Nature 1988; 336: 385-8 https://doi.org/10.1038/336385a0
  2. Moore PK, Oluyomi AO, Babbedge RC, Wallace P, Hart SL: L-$N^G$-nitro arginine methyl ester exhibits anti nociceptive activity in the mouse. Br J Pharmacol 1991; 102: 198-202 https://doi.org/10.1111/j.1476-5381.1991.tb12153.x
  3. Tjolsen A, Berge OG, Hunskaar S, Roseland JH, Hole K: The formalin test: an evaluation of the method. Pain 1992; 51: 5-17 https://doi.org/10.1016/0304-3959(92)90003-T
  4. Dubuisson D, Dennis SG: The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brainstem stimulation in rats and cats. Pain 1977; 4: 161-74 https://doi.org/10.1016/0304-3959(77)90130-0
  5. Hunskaar S, Hole K: The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30:103-14 https://doi.org/10.1016/0304-3959(87)90088-1
  6. Coderre TJ, Vaccarino AI, Melzack R: Central nervous system plasticity in the tonic pain response to subcutaneous formalin injection. Brain Res 1990; 535: 155-8 https://doi.org/10.1016/0006-8993(90)91835-5
  7. Haley JE, Dickenson AH, Schachter M: Elecrrophysiological evidence for a role of nitric oxide in prolonged chemical nociception in rat. Neuropharmacology 1992; 31: 251-8 https://doi.org/10.1016/0028-3908(92)90175-O
  8. Goettl VM, Larson AA: Nitric oxide mediates loog term hyperalgesic and antinociceptive effects of the N-terminus of substance P in the formalin assay in mice. Pain 1996; 67: 435-41 https://doi.org/10.1016/0304-3959(96)03155-7
  9. Malmberg AB, Yaksh TL: Spinal nitric oxide synthesis inhibition blocks NMDA-induced thermal hyperalgesia and produces anti nociception in the formalin test in rats. Pain 1993; 54: 291-300 https://doi.org/10.1016/0304-3959(93)90028-N
  10. Doursout MF, Liang Y, Chelly JE: NOS inhibitors exhibit antinociceptive properties in the rat formalin test. Can J Anaesth 2003;50: 909-16 https://doi.org/10.1007/BF03018738
  11. Puig S, Sorkin LS: Formalin-evoked activity in identified primary afferent fibers: systemic lidocaine suppresses phase-2 activity. Pain 1996; 64: 345-55 https://doi.org/10.1016/0304-3959(95)00121-2
  12. Lee YW: Spinal N-methyl-D-aspartate (NMDA) receptor and pain modulation. Korean J Anesthesiol 1998; 34: 881-9 https://doi.org/10.4097/kjae.1998.34.5.881
  13. Meller ST, Dykstra C, Gebhart GF: Production of endogenous nitric oxide and activation of soluble guanylate cyclase are required for N-methyl-D-aspartate-produced facilitation of nociceptive tail-Hick reflex. Eur J Pharmacol 1992; 214: 93-6 https://doi.org/10.1016/0014-2999(92)90102-A
  14. Lin Q, Peng YB, Wu J, Willis WD: Involvement of c-GMP in nociceptive processing by and sensitization of spinothalamic neurons in primates. J Neurosci 1997; 17: 3293-302 https://doi.org/10.1523/JNEUROSCI.17-09-03293.1997
  15. Mcmahon SB, Lewin GR, Wall PD: Central hyperexcitability triggered by noxious inputs. Curr Opin Neurobiol 1993; 3: 602-10 https://doi.org/10.1016/0959-4388(93)90062-4
  16. Gardiner SM, Compton AM, Kemp PA, Bennett T: Regional and cardiac haemodynamic effect of $N^G$-nitro-L-arginine methyl ester in conscious, Long Evans rats. Br J Pharmacol 1990; 101:625-631 https://doi.org/10.1111/j.1476-5381.1990.tb14131.x